Quoin Pharmaceuticals, Ltd. (QNRX) Misses Q1 EPS by 189c

Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q1 EPS of ($2.13), $1.89 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Morgan Stanley upgrades Ivanhoe Mines, cuts Alcoa and Vale on metals outlook
• Vermilion Energy gets TSX approval to repurchase up to 10% of float